Omeros Corp. (OMER)
13.21
-0.80
(-5.71%)
USD |
NASDAQ |
Nov 20, 16:00
13.22
0.00 (0.00%)
After-Hours: 20:00
Omeros Debt to Equity Ratio : -3.278 for Sept. 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2026 | -3.278 |
| June 30, 2026 | -5.781 |
| March 31, 2026 | -4.905 |
| December 31, 2025 | -3.357 |
| September 30, 2025 | -1.648 |
| June 30, 2025 | -1.670 |
| March 31, 2025 | -1.944 |
| December 31, 2024 | -2.318 |
| September 30, 2024 | -2.811 |
| June 30, 2024 | -3.566 |
| March 31, 2024 | -6.619 |
| December 31, 2023 | -14.47 |
| September 30, 2023 | -33.42 |
| June 30, 2023 | 22.77 |
| March 31, 2023 | 8.510 |
| December 31, 2022 | 5.465 |
| September 30, 2022 | -10.10 |
| June 30, 2022 | -10.49 |
| March 31, 2022 | -69.47 |
| December 31, 2021 | 14.63 |
| September 30, 2021 | -1.326 |
| June 30, 2021 | -1.416 |
| March 31, 2021 | -1.549 |
| December 31, 2020 | -2.195 |
| September 30, 2020 | -3.049 |
| Date | Value |
|---|---|
| June 30, 2020 | -1.225 |
| March 31, 2020 | -1.484 |
| December 31, 2019 | -1.780 |
| September 30, 2019 | -1.34 |
| June 30, 2019 | -1.397 |
| March 31, 2019 | -1.49 |
| December 31, 2018 | -1.512 |
| September 30, 2018 | -1.486 |
| June 30, 2018 | -2.316 |
| March 31, 2018 | -2.928 |
| December 31, 2017 | -30.07 |
| September 30, 2017 | 9.027 |
| June 30, 2017 | -1.491 |
| March 31, 2017 | -1.678 |
| December 31, 2016 | -2.129 |
| September 30, 2016 | -3.095 |
| June 30, 2016 | -1.429 |
| March 31, 2016 | -1.228 |
| December 31, 2015 | -1.900 |
| September 30, 2015 | -3.171 |
| June 30, 2015 | 3.879 |
| March 31, 2015 | 1.507 |
| December 31, 2014 | -0.7668 |
| September 30, 2014 | -1.224 |
| June 30, 2014 | -3.051 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Eli Lilly & Co. | 1.229 |
| Aytu BioPharma, Inc. | 0.5555 |
| Daré Bioscience, Inc. | 2.904 |
| Jaguar Health, Inc. | 0.1731 |
| Structure Therapeutics, Inc. | 0.0056 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 248.10M |
| Total Liabilities (Quarterly) | 338.07M |
| Shareholders Equity (Quarterly) | -89.97M |
| Current Ratio | 2.267 |
| Net Debt Paydown Yield | 1.23% |